H. D. de Freitas

Patients' Preferences for the Treatment of Metastatic Castrate-resistant Prostate Cancer: A Discrete Choice Experiment.

L. Eliasson, B. Calimlim, A. Lloyd, 2017, Clinical therapeutics.

Health state utility valuation in radioactive iodine-refractory differentiated thyroid cancer

C. Kerr, B. Fordham, E. Cohen, 2015, Patient preference and adherence.

Patient Preferences for Metastatic Hormone-Sensitive Prostate Cancer Treatments: A Discrete Choice Experiment Among Men in Three European Countries

Tetsuro Ito, A. Lloyd, M. Hadi, 2019, Advances in Therapy.

The importance of physical function to people with osteoporosis

D. Gold, L. Giangregorio, C. Kerr, 2017, Osteoporosis International.

Estimating utilities/disutilities for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) and treatment-related adverse events

C. Kerr, A. Lloyd, S. Lanar, 2019, Quality of Life Research.

Estimation of Health Utility Scores for Glycogen Storage Disease Type Ia

A. Lloyd, D. Aggio, H. D. de Freitas, 2023, PharmacoEconomics - Open.

Estimating health state utilities in primary hyperoxaluria type 1: a valuation study

A. Lloyd, L. Hubig, H. D. de Freitas, 2023, Journal of medical economics.

A Health State Utility Study to Elicit Societal Values Associated with Pulmonary Hypertension

A. Beaudet, W. Gin-Sing, H. D. de Freitas, 2023, Patient preference and adherence.